Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity Bjarne M. Nes, PhD, Christian R.

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Volume 32, Issue 9, Pages (September 2016)

Relation of Heart Rate at Rest and Long-Term (>20 Years) Death Rate in Initially Healthy Middle-Aged Men Xavier Jouven, MD, PhD, Jean Philippe Empana,

High Positive End-Expiratory Pressure Is Associated with Improved Survival in Obese Patients with Acute Respiratory Distress Syndrome Christian Bime,

Jamie Tam, MPH, Kenneth E. Warner, PhD, Rafael Meza, PhD

Ambulatory Blood Pressure Monitoring in Clinical Practice: A Review

Copyright © 2011 American Medical Association. All rights reserved.

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials Sripal Bangalore, MD, MHA, Bora Toklu,

Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J.

Copyright © 2007 American Medical Association. All rights reserved.

The Effect of Smoking on the Risk of Sciatica: A Meta-analysis

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH

Association of Resistance Exercise With the Incidence of Hypercholesterolemia in Men Esmée A. Bakker, MSc, Duck-chul Lee, PhD, Xuemei Sui, MD, MPH, PhD,

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Longitudinal Patterns of Cardiorespiratory Fitness Predict the Development of Hypertension Among Men and Women Xuemei Sui, MD, MPH, PhD, Mark A. Sarzynski,

Catherine W. Gillespie, PhD, MPH, Pamela E. Morin, MBA

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review Shelley R. Salpeter, MD, Jacob S.

James H. O’Keefe, MD, Salman K. Bhatti, MD, Ata Bajwa, MD, James J

Richard V. Milani, MD, Carl J. Lavie, MD, Robert M

The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study Ido Weinberg, Philimon Gona, Christopher.

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Junxiu Liu, MD, Xuemei Sui, MD, PhD, Carl J. Lavie, MD, James R

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Combined Association of Cardiorespiratory Fitness and Body Fatness With Cardiometabolic Risk Factors in Older Norwegian Adults: The Generation 100 Study

Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:

Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease Nina Raju, MD, MsC, Magdalena Sobieraj-Teague, MBBS, Jack Hirsh, MD,

Epidemiology of Myelodysplastic Syndromes

Protective Effect of Regular Physical Activity on Depression After Myocardial Infarction: The HUNT Study Linda Ernstsen, RN, PhD, Vegar Rangul, PhD,

Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the “Obesity Paradox” Carl J. Lavie, MD, Richard V.

Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients Linong Ji, MD, Dayi Hu, MD, Changyu Pan, MD,

Sabina Hunziker, MD, MPH, Jennifer Stevens, MD, MS, Michael D

Medical professionalism and the generation gap

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Muhammad Amer, MD, MHS, FACP, Rehan Qayyum, MD, MHS

TIA for the Internist The American Journal of Medicine

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials Sripal Bangalore, MD, MHA, Bora Toklu,

Cardiovascular and metabolic profiles of offspring conceived by assisted reproductive technologies: a systematic review and meta-analysis Xiao-Yan Guo,

Cardiac Rehabilitation for Women across the Lifespan

The Obesity Paradox, Weight Loss, and Coronary Disease

Michael A. Weber, MD, George L

Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity Bjarne M. Nes, PhD, Christian R.

Longitudinal Patterns of Cardiorespiratory Fitness Predict the Development of Hypertension Among Men and Women Xuemei Sui, MD, MPH, PhD, Mark A. Sarzynski,

James H. O'Keefe, MD, Robert Vogel, MD, Carl J

Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study Trine Moholdt,

When Guidelines Cause Hypertension

Nonexercise Estimated Cardiorespiratory Fitness and Mortality Due to All Causes and Cardiovascular Disease Yanan Zhang, MSPH, Jiajia Zhang, PhD, Jie.

Molly E. Waring, PhD, Jane S

Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy Scott J. Denardo, MD, Yan Gong, PhD, Wilmer.

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD Rachael L. Morton, PhD, Iryna Schlackow, DPhil, Natalie Staplin, PhD, Alastair.

Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data Michael L. Eisenberg, M.D., Shufeng Li,

Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.

Sophie K. Kieffer, Nina Zisko, PhD, Jeff S

Prevalence and Risk Factors for Erectile Dysfunction in the US

Nilay S. Shah, MD, MPH, David Leonard, PhD, Carrie E

Age Differences in Treatment and Control of Hypertension in US Physician Offices, : A Serial Cross-sectional Study Anna Gu, MD, PhD, Yu Yue,

One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta- analysis of Randomized Trials David S. Wald, MD, FRCP, Shahena Butt, MSc,

Sodium Intake and Mortality in the NHANES II Follow-up Study

ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome Lucas Bandeira Marchesan, B.Sc., Poli Mara Spritzer,

Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm

Alcohol Intake More than Doubles the Risk of Early Cardiovascular Events in Young Hypertensive Smokers Paolo Palatini, MD, Claudio Fania, MD, Lucio Mos,

Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D

Volume 75, Issue 1, Pages (January 2009)

Is There an “Asymptote of Gain” Beyond Which Further Increases in Cardiorespiratory Fitness Convey No Additional Benefits on Mortality and Atrial Fibrillation?

Baseline Q Waves and Time From Symptom Onset to ST-segment Elevation Myocardial Infarction: Insights From PLATO on the Influence of Sex Naji Kholaif,

Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G

Higher Cardiovascular Disease Prevalence and Mortality among Younger Blacks Compared to Whites Stacey Jolly, MD, MS, Eric Vittinghoff, PhD, Arpita Chattopadhyay,

Direct Observation of Residents: A Model for an Assessment System

Surgical decortication as the first-line treatment for pleural empyema

Jacob J.E. Koopman, MD, PhD American Journal of Kidney Diseases

Presentation transcript:

Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity Bjarne M. Nes, PhD, Christian R. Gutvik, PhD, Carl J. Lavie, MD, Javaid Nauman, PhD, Ulrik Wisløff, PhD The American Journal of Medicine Volume 130, Issue 3, Pages 328-336 (March 2017) DOI: 10.1016/j.amjmed.2016.09.031 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Hazard ratios of death associated with personalized activity intelligence in age groups (years). (A) All-cause mortality in men; (B) all-cause mortality in women; (C) cardiovascular disease mortality in men; (D) cardiovascular disease mortality in women. CI = confidence interval. The American Journal of Medicine 2017 130, 328-336DOI: (10.1016/j.amjmed.2016.09.031) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Hazard ratios of death associated with personalized activity intelligence in sub-groups. (A) All-cause mortality in men; (B) all-cause mortality in women; (C) cardiovascular disease mortality in men; (D) cardiovascular disease mortality in women. Overweight/obesity was body mass index ≥25 kg·m−2. Hypertension was defined as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or taking blood pressure medication. CI = confidence interval. The American Journal of Medicine 2017 130, 328-336DOI: (10.1016/j.amjmed.2016.09.031) Copyright © 2016 The Authors Terms and Conditions